← SynDRA
IMRECOXIB
SynDRA canonical compound SYN0018894 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | PTGS2 |
|---|
| Mechanism of action | cyclooxygenase inhibitor |
|---|
| Indication | osteoarthritis |
|---|
| Disease area | rheumatology |
|---|
All known targets
Mechanisms of action (all sources)
- cyclooxygenase inhibitor
- PTGS1 INHIBITOR
- PTGS2 INHIBITOR
Cross-references
Synonyms
- BAP-909
- UNII-SGW6W5758V
- SGW6W5758V
- CHEMBL504535
- Imricoxib
- SCHEMBL3034253
- BDBM50293282
- AKOS032954049
- DB12354
- LS-194053
- 2H-Pyrrol-2-one, 1,5-dihydro-3-(4-methylphenyl)-4-(4-(methylsulfonyl)phenyl)-1-propyl-
- RefChem:148054
- Imrecoxib (Standard)
- IMRECOXIB [WHO-DD]
- orb1308200
- HY-114200R
- DA-54296
- MS-25939
- HY-114200
- CS-0079499
- NS00069613
- F82319
- T15571
- F979439
Look up IMRECOXIB in the interactive SynDRA portal →